Clinical, Imaging, and Follow-Up Patient Data
| Age (y) | Sex | Primary tumor site | Histology | 18F-FDG PET | Skeletal scintigraphy | Follow-up | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| T/NTav | T/NTmax | T/NTav | T/NTmax | Period (mo) | Course | Current status | ||||||||
| 5 | F | Proximal tibia | Fibroblastic | 3.9 | 10.3 | 6.9 | 18.2 | 16 | CR1 | CR | ||||
| 5 | M | Distal femur | Osteoblastic | 4.4 | 3.7 | 7.8 | — | 68 | CR1 | CR | ||||
| 6 | M | Distal femur | Osteoblastic | 6.4 | 22.8 | 5.0 | 14.6 | 16 | CR1, R1 (o) | DFD | ||||
| 8 | M | Distal femur | Fibroblastic | 7.7 | 32.4 | 5.9 | 19.2 | 7 | CR1 | CR | ||||
| 9 | F | Proximal tibia | Small cell | 4.0 | 9.4 | 6.0 | 18.2 | 49 | CR1 | CR | ||||
| 9 | M | Distal femur | Osteoblastic | 4.8 | 7.5 | 4.6 | — | 70 | CR1 | CR | ||||
| 9 | M | Proximal femur* | Osteoblastic | 4.5 | 12.6 | 3.3 | — | 28 | CR1, R1 (p, o) | DFD | ||||
| 11 | M | Distal femur | Osteoblastic | 4.8 | 8.3 | 2.6 | — | 72 | CR1 | CR | ||||
| 11 | M | Proximal tibia | Fibroblastic | 3.7 | 10.6 | 2.8 | 12.8 | 28 | CR1 | CR | ||||
| 11 | M | Ulna | Teleangiectatic | 5.3 | 23.1 | 9.1 | 31.7 | 14 | CR1 | CR | ||||
| 12 | F | Distal femur | Osteoblastic | 5.1 | 14.7 | 2.9 | — | 64 | CR1 | CR | ||||
| 12 | M | Proximal tibia | No diff. | 7.9 | 22.1 | 2.7 | 6.5 | 44 | CR1, R1 (p), CR2 | CR | ||||
| 13 | F | Distal femur | No diff. | 9.7 | 32.8 | 5.0 | 12.9 | 27 | CR1 | CR | ||||
| 13 | M | Distal femur | Fibroblastic | 3.7 | 8.3 | 5.7 | 5.9 | 33 | CR1 | CR | ||||
| 14 | F | Distal tibia | Fibroblastic | 11.0 | 33.0 | 3.9 | 20.5 | 18 | CR1 | CR | ||||
| 14 | M | Distal femur | Sclerotic | 2.7 | 8.6 | 2.8 | — | 41 | CR1, R1 (l, p), CR2, R2 (p) | DFD | ||||
| 14 | M | Proximal tibia | Osteoblastic | 2.6 | 5.5 | 3.2 | — | 65 | CR1 | CR | ||||
| 15 | F | Distal femur | Osteoblastic | 1.8 | 4.4 | 2.1 | 3.7 | 41 | CR1 | CR | ||||
| 15 | F | Distal femur | Osteoblastic | 19.2 | 96.3 | 16.2 | 15.7 | 7 | CR1 | CR | ||||
| 15 | F | Humerus* | Osteoblastic | 2.9 | 9.8 | 17.3 | 40.9 | 20 | CR1 | CR | ||||
| 15 | M | Proximal tibia | Chondroblastic | 3.8 | 7.7 | 3.5 | 8.9 | 42 | CR1 | CR | ||||
| 16 | M | Distal femur | Osteoblastic | 8.2 | 39.8 | 9.0 | 13.6 | 25 | CR1, R1 (o, p) | AD | ||||
| 17 | M | Femur* | No diff. | 6.5 | 18.4 | 7.7 | 15.4 | 30 | CR1 | CR | ||||
| 17 | M | Proximal tibia | Fibroblastic | 1.6 | 3.2 | 2.9 | 13.8 | 21 | CR1 | CR | ||||
| 21 | M | Proximal tibia | Fibroblastic | 4.4 | 26.6 | 12.7 | 37.6 | 34 | CR1, R1 (l, p) | AD | ||||
| 22 | M | Fibula | No diff. | 6.8 | 23.3 | 21.8 | 49.3 | 45 | CR1, R1 (p, o) | DFD | ||||
| 23 | F | Distal femur* | Osteoblastic | 3.5 | 10.4 | 22.8 | 60.3 | 11 | CR1 | CR | ||||
| 35 | F | Distal femur | Osteoblastic | 9.0 | 26.5 | 14.7 | 40.2 | 18 | CR1, R1 (p) | DFD | ||||
| 41 | F | Pelvis* | Osteoblastic | 1.7 | 18.1 | 4.0 | 10.9 | 26 | No CR | DFD | ||||
↵* Primary metastatic disease.
CR = complete remission; R = relapse; o = osseous; DFD = dead from disease; p = pulmonary; no diff. = no differentiation possible; l = local; AD = alive, with disease.